Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention

References

• WHO. (2023). Depressive disorder (depression). World Health Organization [Internet]. [cited 2023 Apr 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression.
   Google Scholar
• Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547, doi:10.1371/journal.pmed.1001547.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. Am J Psychiatry. 2006;163(11):1905–17. doi:10.1176/ajp.2006.163.11.1905.
   PubMed Web of Science ®Google Scholar
• Heerlein K, Young AH, Otte C, Frodl T, Degraeve G, Hagedoorn W, et al. Real-world evidence from a European Cohort Study of patients with treatment resistant depression: baseline patient characteristics. J Affect Disord. 2021;283:115–22. doi:10.1016/j.jad.2020.11.124.
   PubMed Web of Science ®Google Scholar
• Jaffe DH, Rive B, Denee TR. The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry. 2019;19(1):247. doi:10.1186/s12888-019-2222-4.
   PubMed Web of Science ®Google Scholar
• Ng CH, Kato T, Han C, Wang G, Trivedi M, Ramesh V, et al. Definition of treatment-resistant depression – Asia pacific perspectives. J Affect Disord. 2019;245:626–36. doi:10.1016/j.jad.2018.11.038.
   PubMed Web of Science ®Google Scholar
• Papp M, Cubała WJ, Swiecicki L, Newman-Tancredi A, Willner P. Perspectives for therapy of treatment-resistant depression. Br J Pharmacol. 2022;179(17):4181–200. doi:10.1111/bph.15596.
   PubMed Web of Science ®Google Scholar
• Wilkowska A, Cubała WJ. The downstaging concept in treatment-resistant depression: spotlight on ketamine. Int J Mol Sci. 2022;23(23):14605. doi:10.3390/ijms232314605.
   PubMed Web of Science ®Google Scholar
• Kasper S. Is treatment-resistant depression really resistant? Eur Neuropsychopharmacol. 2022;58:44–6. doi:10.1016/j.euroneuro.2022.02.001.
   PubMed Web of Science ®Google Scholar
• van Belkum SM, Geugies H, Lysen TS, Cleare AJ, Peeters FPML, Penninx BWJH, et al. Validity of the maudsley staging method in predicting treatment-resistant depression outcome using The Netherlands study of depression and anxiety. J Clin Psychiatry. 2018;79(1):17m11475. doi:10.4088/JCP.17m11475.
   PubMed Web of Science ®Google Scholar
• Salloum NC, Papakostas GI. Staging treatment intensity and defining resistant depression: historical overview and future directions. J Clin Psychiatry. 2019;80(4). doi:10.4088/JCP.18r12250.
   PubMed Web of Science ®Google Scholar
• Vázquez GH, Bahji A, Undurraga J, Tondo L, Baldessarini RJ. Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs. esketamine vs. lithium. J Psychopharmacol. 2021;35(8):890–900. doi:10.1177/02698811211013579.
   PubMed Web of Science ®Google Scholar
• Nuñez NA, Joseph B, Pahwa M, Kumar R, Resendez MG, Prokop LJ, et al. Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis. J Affect Disord. 2022;302:385–400. doi:10.1016/j.jad.2021.12.134.
   PubMed Web of Science ®Google Scholar
• Sarris J, Ravindran A, Yatham LN, Marx W, Rucklidge JJ, McIntyre RS, et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) taskforce. World J Biol Psychiatry. 2022;23(6):424–55. doi:10.1080/15622975.2021.2013041.
   PubMed Web of Science ®Google Scholar
• Levinta A, Meshkat S, McIntyre RS, Ho C, Lui LM, Lee Y, et al. The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: a systematic review. J Affect Disord. 2022;318:139–49. doi:10.1016/j.jad.2022.08.050.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Stahl SM. Co-administration in the treatment of depression: deconstructing the tower of babel? Eur Neuropsychopharmacol. 2023;72:1–3. doi:10.1016/j.euroneuro.2023.03.002.
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J. 2008;7(1):2. doi:10.1186/1475-2891-7-2.
   PubMedGoogle Scholar
• Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zięba A, Popik P, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord. 2009;118(1–3):187–95. doi:10.1016/j.jad.2009.02.014.
   PubMed Web of Science ®Google Scholar
• Włodarczyk A, Cubała WJ, Stawicki M. Ketogenic diet for depression: a potential dietary regimen to maintain euthymia? Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;109:110257. doi:10.1016/j.pnpbp.2021.110257.
   PubMed Web of Science ®Google Scholar
• Annadurai K, Danasekaran R, Mani G. Nutritional psychiatry: an evolving concept. J Res Med Sci. 2017;22(1):88. doi:10.4103/jrms.JRMS_75_17.
   PubMedGoogle Scholar
• Juul F, Parekh N, Martinez-Steele E, Monteiro CA, Chang VW. Ultra-processed food consumption among US adults from 2001 to 2018. Am J Clin Nutr. 2022;115(1):211–21. doi:10.1093/ajcn/nqab305.
   PubMed Web of Science ®Google Scholar
• Chomistek AK, Chiuve SE, Eliassen AH, Mukamal KJ, Willett WC, Rimm EB. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol. 2015;65(1):43–51. doi:10.1016/j.jacc.2014.10.024.
   PubMed Web of Science ®Google Scholar
• Konikowska K, Bombała W, Szuba A, Różańska D, Regulska-Ilow B. Metabolic syndrome is associated with low diet quality assessed by the Healthy Eating Index-2015 (HEI-2015) and low concentrations of high-density lipoprotein cholesterol. Biomedicines. 2022;10(10):2487. doi:10.3390/biomedicines10102487.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337. doi:10.1093/eurheartj/ehab484.
   PubMed Web of Science ®Google Scholar
• Mechlińska A, Wiglusz MS, Słupski J, Włodarczyk A, Cubała WJ. Exploring the relationship between mood disorders and coexisting health conditions: the focus on nutraceuticals. Brain Sci. 2023;13(9):1262. doi:10.3390/brainsci13091262.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94. doi:10.1016/j.bbi.2015.03.016.
   PubMed Web of Science ®Google Scholar
• Bostock ECS, Kirkby KC, Taylor BVM. The current status of the ketogenic diet in psychiatry. Front Psychiatry. 2017;8. doi:10.3389/fpsyt.2017.00043.
   Web of Science ®Google Scholar
• Włodarczyk A, Wiglusz MS, Cubała WJ. Ketogenic diet for schizophrenia: nutritional approach to antipsychotic treatment. Med Hypotheses. 2018;118:74–77. doi:10.1016/j.mehy.2018.06.022.
   PubMed Web of Science ®Google Scholar
• Cicek E, Sanlier N. The place of a ketogenic diet in the treatment of resistant epilepsy: a comprehensive review. Nutr Neurosci. 2022;26(9):1–14. doi:10.1080/1028415X.2022.2095819.
   Web of Science ®Google Scholar
• Chmiel I. Ketogenic diet in therapy of bipolar affective disorder - case report and literature review. Psychiatry Pol. 2022;56(6):1345–63. doi:10.12740/PP/OnlineFirst/136356.
   PubMed Web of Science ®Google Scholar
• Danan A, Westman EC, Saslow LR, Ede G. The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients. Front Psychiatry. 2022;13:951376. doi:10.3389/fpsyt.2022.951376.
   PubMed Web of Science ®Google Scholar
• Dietch DM, Kerr-Gaffney J, Hockey M, Marx W, Ruusunen A, Young AH, et al. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open. 2023;9(3):e70. doi:10.1192/bjo.2023.36.
   PubMed Web of Science ®Google Scholar
• Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry. 2011;16(4):383–406. doi:10.1038/mp.2010.120.
   PubMed Web of Science ®Google Scholar
• Włodarczyk A, Cubała WJ. Mechanisms of action of the ketogenic diet in depression. Neurosci Biobehav Rev. 2019;107:422–3. doi:10.1016/j.neubiorev.2019.09.038.
   PubMed Web of Science ®Google Scholar
• Beilharz J, Maniam J, Morris M. Diet-induced cognitive deficits: the role of fat and sugar, potential mechanisms and nutritional interventions. Nutrients. 2015;7(8):6719–38. doi:10.3390/nu7085307.
   PubMed Web of Science ®Google Scholar
• Glud M, Christiansen T, Larsen LH, Richelsen B, Bruun JM. Changes in circulating BDNF in relation to sex, diet, and exercise: a 12-week randomized controlled study in overweight and obese participants. J Obes. 2019;2019:1–7. doi:10.1155/2019/4537274.
   Web of Science ®Google Scholar
• Albert PR. Adult neuroplasticity: a new “cure” for major depression? J Psychiatry Neurosci. 2019;44(3):147–50. doi:10.1503/jpn.190072.
   PubMed Web of Science ®Google Scholar
• Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006;67(12):1954–67. doi:10.4088/JCP.v67n1217.
   PubMed Web of Science ®Google Scholar
• Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31(6):761–77. doi:10.1159/000350094.
   PubMed Web of Science ®Google Scholar
• Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional aspects of depression. Cell Physiol Biochem. 2015;37(3):1029–43. doi:10.1159/000430229.
   PubMed Web of Science ®Google Scholar
• Renteria K, Nguyen H, Koh GY. The role of vitamin D in depression and anxiety disorders: a review of the literature. Nutr Neurosci. 2023: 1–9. doi:10.1080/1028415X.2023.2186318.
   PubMed Web of Science ®Google Scholar
• Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, Attia J. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord. 2014;166:249–57. doi:10.1016/j.jad.2014.05.016.
   PubMed Web of Science ®Google Scholar
• Ghafari M, Whittle N, Miklósi AG, Kotlowsky C, Schmuckermair C, Berger J, et al. Dietary magnesium restriction reduces amygdala–hypothalamic GluN1 receptor complex levels in mice. Brain Struct Funct. 2015;220(4):2209–21. doi:10.1007/s00429-014-0779-8.
   PubMed Web of Science ®Google Scholar
• Chou M-H, Yang YK, Wang J-D, Lin C-Y, Lin S-H. The association of serum and dietary magnesium with depressive symptoms. Nutrients. 2023;15(3):774. doi:10.3390/nu15030774.
   PubMed Web of Science ®Google Scholar
• Jalali-Yazdi F, Chowdhury S, Yoshioka C, Gouaux E. Mechanisms for zinc and proton inhibition of the GluN1/GluN2A NMDA receptor. Cell. 2018;175(6):1520–32.e15. doi:10.1016/j.cell.2018.10.043.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang H, Zhang H, Chen X, Zhang Y, Wu J, et al. Toward a deeper understanding of gut microbiome in depression: the promise of clinical applicability. Adv Sci. 2022;9(35):2203707. doi:10.1002/advs.202203707.
   Web of Science ®Google Scholar
• Zhang Y, Fan Q, Hou Y, Zhang X, Yin Z, Cai X, et al. Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. Brain Behav Immun. 2022;102:11–22. doi:10.1016/j.bbi.2022.02.007.
   PubMed Web of Science ®Google Scholar
• Liu S, Guo R, Liu F, Yuan Q, Yu Y, Ren F. Gut microbiota regulates depression-like behavior in rats through the neuroendocrine-immune-mitochondrial pathway. Neuropsychiatr Dis Treat. 2020;16:859–69. doi:10.2147/NDT.S243551.
   PubMed Web of Science ®Google Scholar
• Knudsen JK, Michaelsen TY, Bundgaard-Nielsen C, Nielsen RE, Hjerrild S, Leutscher P, et al. Faecal microbiota transplantation from patients with depression or healthy individuals into rats modulates mood-related behaviour. Sci Rep. 2021;11(1):21869. doi:10.1038/s41598-021-01248-9.
   PubMed Web of Science ®Google Scholar
• Maybee J, Pearson T, Elliott L. The gut-brain-microbiome connection: can probiotics decrease anxiety and depression? Issues Ment Health Nurs. 2022;43(11):996–1003. doi:10.1080/01612840.2022.2106525.
   PubMed Web of Science ®Google Scholar
• Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019;38(2):522–8. doi:10.1016/j.clnu.2018.04.010.
   PubMed Web of Science ®Google Scholar
• Vaghef-Mehrabany E, Maleki V, Behrooz M, Ranjbar F, Ebrahimi-Mameghani M. Can psychobiotics “mood” ify gut? An update systematic review of randomized controlled trials in healthy and clinical subjects, on anti-depressant effects of probiotics, prebiotics, and synbiotics. Clin Nutr. 2020;39(5):1395–410. doi:10.1016/j.clnu.2019.06.004.
   PubMed Web of Science ®Google Scholar
• Warnerschmidt J, Duman R. Vegf as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol. 2008;8(1):14–9. doi:10.1016/j.coph.2007.10.013.
   PubMed Web of Science ®Google Scholar
• Castrén E, Monteggia LM. Brain-derived neurotrophic factor signaling in depression and antidepressant action. Biol Psychiatry. 2021;90(2):128–36. doi:10.1016/j.biopsych.2021.05.008.
   PubMed Web of Science ®Google Scholar
• Papp M, Willner P. Models of affective illness: chronic mild stress in the rat. Curr Protocols. 2023;3(3):e712. doi:10.1002/cpz1.712.
   PubMedGoogle Scholar
• Kucharczyk M, Kurek A, Detka J, Slusarczyk J, Papp M, Tota K, et al. Chronic mild stress influences nerve growth factor through a matrix metalloproteinase-dependent mechanism. Psychoneuroendocrinology. 2016;66:11–21. doi:10.1016/j.psyneuen.2015.12.019.
   PubMed Web of Science ®Google Scholar
• Phillips C. Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plast. 2017;2017:1–17. doi:10.1155/2017/7260130.
   Web of Science ®Google Scholar
• Zatorre RJ, Fields RD, Johansen-Berg H. Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat Neurosci. 2012;15(4):528–36. doi:10.1038/nn.3045.
   PubMed Web of Science ®Google Scholar
• Duman RS, Deyama S, Fogaça MV. Role of BDNF in the pathophysiology and treatment of depression: activity-dependent effects distinguish rapid-acting antidepressants. Eur J Neurosci. 2021;53(1):126–39. doi:10.1111/ejn.14630.
   PubMed Web of Science ®Google Scholar
• de Menezes Galvao AC, Almeida RN, de Sousa GM Jr, Leocadio-Miguel MA, Palhano-Fontes F, de Araujo DB, et al. Pathophysiology of major depression by clinical stages. Front Psychol. 2021;12:641779. doi:10.3389/fpsyg.2021.641779.
   PubMed Web of Science ®Google Scholar
• Cubillos S, Engmann O, Brancato A. BDNF as a mediator of antidepressant response: recent advances and lifestyle interactions. IJMS. 2022;23(22):14445. doi:10.3390/ijms232214445.
   Google Scholar
• Dunham JS, Deakin JFW, Miyajima F, Payton A, Toro CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in stanley consortium brains. J Psychiatr Res. 2009;43(14):1175–84. doi:10.1016/j.jpsychires.2009.03.008.
   PubMed Web of Science ®Google Scholar
• Ray MT, Weickert CS, Wyatt E, Webster MJ. Decreased BDNF, trkB-TK+ and GAD 67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. J Psychiatry Neurosci. 2011;36(3):195–203. doi:10.1503/jpn.100048.
   PubMed Web of Science ®Google Scholar
• Guilloux J-P, Douillard-Guilloux G, Kota R, Wang X, Gardier AM, Martinowich K, et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry. 2012;17(11):1130–42. doi:10.1038/mp.2011.113.
   PubMed Web of Science ®Google Scholar
• Tripp A, Oh H, Guilloux J-P, Martinowich K, Lewis DA, Sibille E. Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry. 2012;169(11):1194–202. doi:10.1176/appi.ajp.2012.12020248.
   PubMed Web of Science ®Google Scholar
• Youssef MM, Underwood MD, Huang Y-Y, Hsiung S, Liu Y, Simpson NR, et al. Association of BDNF Val66Met polymorphism and brain BDNF levels with major depression and suicide. Int J Neuropsuchopharmacol. 2018;21(6):528–38. doi:10.1093/ijnp/pyy008.
   PubMed Web of Science ®Google Scholar
• Piccinni A, Marazziti D, Catena M, Domenici L, Del Debbio A, Bianchi C, et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord. 2008;105(1–3):279–83. doi:10.1016/j.jad.2007.05.005.
   PubMed Web of Science ®Google Scholar
• Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res. 2009;43(3):247–54. doi:10.1016/j.jpsychires.2008.03.014.
   PubMed Web of Science ®Google Scholar
• Caraci F, Copani A, Nicoletti F, Drago F. Depression and Alzheimer’s disease: neurobiological links and common pharmacological targets. Eur J Pharmacol. 2010;626(1):64–71. doi:10.1016/j.ejphar.2009.10.022.
   PubMed Web of Science ®Google Scholar
• Autry AE, Monteggia LM. Brain-Derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev. 2012;64(2):238–58. doi:10.1124/pr.111.005108.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee KH, Kim SH, Han JY, Hong S-B, Cho S-C, et al. Early changes of serum BDNF and SSRI response in adolescents with major depressive disorder. J Affect Disord. 2020;265:325–32. doi:10.1016/j.jad.2020.01.045.
   PubMed Web of Science ®Google Scholar
• Casarotto PC, Girych M, Fred SM, Kovaleva V, Moliner R, Enkavi G, et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell. 2021;184(5):1299–313.e19. doi:10.1016/j.cell.2021.01.034.
   PubMed Web of Science ®Google Scholar
• Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2017;97:119–26. doi:10.1016/j.nbd.2016.07.010.
   PubMed Web of Science ®Google Scholar
• Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856. doi:10.1001/archpsyc.63.8.856.
   PubMed Web of Science ®Google Scholar
• Lepack AE, Bang E, Lee B, Dwyer JM, Duman RS. Fast-acting antidepressants rapidly stimulate ERK signaling and BDNF release in primary neuronal cultures. Neuropharmacology. 2016;111:242–52. doi:10.1016/j.neuropharm.2016.09.011.
   PubMed Web of Science ®Google Scholar
• FDA. (2023). FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic. [cited 2023 Mar 21]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified.
   Google Scholar
• Molteni R, Barnard RJ, Ying Z, Roberts CK, Gómez-Pinilla F. A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning. Neuroscience. 2002;112(4):803–14. doi:10.1016/S0306-4522(02)00123-9.
   PubMed Web of Science ®Google Scholar
• Tyagi E, Zhuang Y, Agrawal R, Ying Z, Gomez-Pinilla F. Interactive actions of bdnf methylation and cell metabolism for building neural resilience under the influence of diet. Neurobiol Dis. 2015;73:307–18. doi:10.1016/j.nbd.2014.09.014.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhu Z, Kalyani M, Janik JM, Shi H. Effects of energy status and diet on bdnf expression in the ventromedial hypothalamus of male and female rats. Physiol Behav. 2014;130:99–107. doi:10.1016/j.physbeh.2014.03.028.
   PubMed Web of Science ®Google Scholar
• Genzer Y, Dadon M, Burg C, Chapnik N, Froy O. Effect of dietary fat and the circadian clock on the expression of brain-derived neurotrophic factor (BDNF). Mol Cell Endocrinol. 2016;430:49–55. doi:10.1016/j.mce.2016.04.015.
   PubMed Web of Science ®Google Scholar
• Mohorko N, Černelič-Bizjak M, Poklar-Vatovec T, Grom G, Kenig S, Petelin A, Jenko-Pražnikar Z. Weight loss, improved physical performance, cognitive function, eating behavior, and metabolic profile in a 12-week ketogenic diet in obese adults. Nutr Res. 2019;62:64–77. doi:10.1016/j.nutres.2018.11.007.
   PubMed Web of Science ®Google Scholar
• Araya AV, Orellana X, Espinoza J. Evaluation of the effect of caloric restriction on serum BDNF in overweight and obese subjects: preliminary evidences. Endocrinology. 2008;33(3):300–4. doi:10.1007/s12020-008-9090-x.
   Google Scholar
• Gyorkos A, Baker MH, Miutz LN, Lown DA, Jones MA, Houghton-Rahrig LD. Carbohydrate-restricted diet and exercise increase brain-derived neurotrophic factor and cognitive function: a randomized crossover trial. Cureus. 2019. doi:10.7759/cureus.5604.
   Web of Science ®Google Scholar
• Li B, Lang N, Cheng Z-F. Serum levels of brain-derived neurotrophic factor are associated with diabetes risk, complications, and obesity: a cohort study from Chinese patients with type 2 diabetes. Mol Neurobiol. 2016;53(8):5492–9. doi:10.1007/s12035-015-9461-2.
   PubMed Web of Science ®Google Scholar
• Sumbul-Sekerci B, Sekerci A, Pasin O, Durmus E, Yuksel-Salduz ZI. Cognition and BDNF levels in prediabetes and diabetes: a mediation analysis of a cross-sectional study. Front Endocrinol. 2023;14:1120127. doi:10.3389/fendo.2023.1120127.
   PubMed Web of Science ®Google Scholar
• Oh R, Gilani B, Uppaluri KR. (2023). Low carbohydrate diet [Internet]. [cited 2023 Mar 23]. Available from: www.ncbi.nlm.nih.gov/books/NBK537084/.
   Google Scholar
• El Ghoch M, Calugi S, Dalle Grave R. The effects of low-carbohydrate diets on psychosocial outcomes in obesity/overweight: a systematic review of randomized, controlled studies. Nutrients. 2016;8(7):402. doi:10.3390/nu8070402.
   PubMed Web of Science ®Google Scholar
• Arab A, Mehrabani S, Moradi S, Amani R. The association between diet and mood: a systematic review of current literature. Psychiatry Res. 2019;271:428–37. doi:10.1016/j.psychres.2018.12.014.
   PubMed Web of Science ®Google Scholar
• Varaee H, Darand M, Hassanizadeh S, Hosseinzadeh M. Effect of low-carbohydrate diet on depression and anxiety: a systematic review and meta-analysis of controlled trials. J Affect Disord. 2023;325:206–14. doi:10.1016/j.jad.2022.12.030.
   PubMed Web of Science ®Google Scholar
• IJff DM, Postulart D, Lambrechts DAJE, Majoie MHJM, de Kinderen RJA, Hendriksen JGM, et al. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: a randomized controlled trial. Epilepsy Behav. 2016;60:153–7. doi:10.1016/j.yebeh.2016.04.033.
   PubMed Web of Science ®Google Scholar
• Lambrechts DAJE, Wielders LHP, Aldenkamp AP, Kessels FGH, de Kinderen RJA, Majoie MJM. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav. 2012;23(3):310–4. doi:10.1016/j.yebeh.2012.01.002.
   PubMed Web of Science ®Google Scholar
• McClernon FJ, Yancy WS, Eberstein JA, Atkins RC, Westman EC. The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms. Obesity. 2007;15(1):182–. doi:10.1038/oby.2007.516.
   PubMed Web of Science ®Google Scholar
• Hu M, Shi Q, Sun S, Hong HI, Zhang H, Qi F, et al. Effect of a low-carbohydrate diet with or without exercise on anxiety and eating behavior and associated changes in cardiometabolic health in overweight young women. Front Nutr. 2022;9:894916. doi:10.3389/fnut.2022.894916.
   PubMed Web of Science ®Google Scholar
• Cox N, Gibas S, Salisbury M, Gomer J, Gibas K. Ketogenic diets potentially reverse type II diabetes and ameliorate clinical depression: A case study. Diabetes Metabol Syndr Clin Res Rev. 2019;13(2):1475–9. doi:10.1016/j.dsx.2019.01.055.
   PubMed Web of Science ®Google Scholar
• García-Montero C, Fraile-Martinez O, Gomez-Lahoz AM, Pekarek L, Castellanos AJ, Noguerales-Fraguas F, et al. Nutritional components in western diet versus Mediterranean diet at the gut microbiota–immune system interplay. Implications for health and disease. Nutrients. 2021;13(2):699. doi:10.3390/nu13020699.
   PubMed Web of Science ®Google Scholar
• Matison AP, Mather KA, Flood VM, Reppermund S. Associations between nutrition and the incidence of depression in middle-aged and older adults: a systematic review and meta-analysis of prospective observational population-based studies. Age Res Rev. 2021;70:101403. doi:10.1016/j.arr.2021.101403.
   PubMed Web of Science ®Google Scholar
• Taylor ZB, Stevenson RJ, Ehrenfeld L, Francis HM. The impact of saturated fat, added sugar and their combination on human hippocampal integrity and function: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;130:91–106. doi:10.1016/j.neubiorev.2021.08.008.
   PubMed Web of Science ®Google Scholar
• Sangsefidi ZS, Salehi-Abarghouei A, Sangsefidi ZS, Mirzaei M, Hosseinzadeh M. The relation between low carbohydrate diet score and psychological disorders among Iranian adults. Nutr Metab (Lond). 2021;18(1):16. doi:10.1186/s12986-021-00546-3.
   PubMed Web of Science ®Google Scholar
• Daneshzad E, Keshavarz S, Qorbani M, Larijani B, Azadbakht L. Association between a low-carbohydrate diet and sleep status, depression, anxiety, and stress score. J Sci Food Agric. 2020;100(7):2946–52. doi:10.1002/jsfa.10322.
   PubMed Web of Science ®Google Scholar
• Jacka FN, O’Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med. 2017;15(1):23. doi:10.1186/s12916-017-0791-y.
   PubMed Web of Science ®Google Scholar
• Francis HM, Stevenson RJ, Chambers JR, Gupta D, Newey B, Lim CK. A brief diet intervention can reduce symptoms of depression in young adults – a randomised controlled trial. PLoS One. 2019;14(10):e0222768. doi:10.1371/journal.pone.0222768.
   PubMed Web of Science ®Google Scholar
• Cheatham RA, Roberts SB, Das SK, Gilhooly CH, Golden JK, Hyatt R, et al. Long-term effects of provided low and high glycemic load low energy diets on mood and cognition. Physiol Behav. 2009;98(3):374–9. doi:10.1016/j.physbeh.2009.06.015.
   PubMed Web of Science ®Google Scholar
• Breymeyer KL, Lampe JW, McGregor BA, Neuhouser ML. Subjective mood and energy levels of healthy weight and overweight/obese healthy adults on high-and low-glycemic load experimental diets. Appetite. 2016;107:253–9. doi:10.1016/j.appet.2016.08.008.
   PubMed Web of Science ®Google Scholar
• Malik VS, Hu FB. Fructose and cardiometabolic health. J Am Coll Cardiol. 2015;66(14):1615–24. doi:10.1016/j.jacc.2015.08.025.
   PubMed Web of Science ®Google Scholar
• Hu D, Cheng L, Jiang W. Sugar-sweetened beverages consumption and the risk of depression: a meta-analysis of observational studies. J Affect Disord. 2019;245:348–55. doi:10.1016/j.jad.2018.11.015.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu Y, Shi M, Zhou Y, Zhao Y, Xia Y. Meta-analysis of sugar-sweetened beverage intake and the risk of cognitive disorders. J Affect Disord. 2022;313:177–85. doi:10.1016/j.jad.2022.06.048.
   PubMed Web of Science ®Google Scholar
• Pérez-Ara MÁ, Gili M, Visser M, Penninx BW, Brouwer IA, Watkins E, et al. Associations of non-alcoholic beverages with major depressive disorder history and depressive symptoms clusters in a sample of overweight adults. Nutrients. 2020;12(10):3202. doi:10.3390/nu12103202.
   PubMed Web of Science ®Google Scholar
• Chen C, Lu Z, Zhao J, Wang X, Zhang J, Zhang D, Li S. Combined association of depressive symptoms and sugar-sweetened beverages consumption with low cognitive performance. J Affect Disord. 2022;313:15–20. doi:10.1016/j.jad.2022.06.071.
   PubMed Web of Science ®Google Scholar
• de la Iglesia R, Loria-Kohen V, Zulet M, Martinez J, Reglero G, Ramirez de Molina A. Dietary strategies implicated in the prevention and treatment of metabolic syndrome. IJMS. 2016;17(11):1877. doi:10.3390/ijms17111877.
   Google Scholar
• Ostman C, Smart NA, Morcos D, Duller A, Ridley W, Jewiss D. The effect of exercise training on clinical outcomes in patients with the metabolic syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2017;16(1):110. doi:10.1186/s12933-017-0590-y.
   PubMedGoogle Scholar
• Papadaki A, Nolen-Doerr E, Mantzoros CS. The effect of the Mediterranean diet on metabolic health: a systematic review and meta-analysis of controlled trials in adults. Nutrients. 2020;12(11):3342. doi:10.3390/nu12113342.
   PubMed Web of Science ®Google Scholar
• Clifton P. Metabolic syndrome – role of dietary fat type and quantity. Nutrients. 2019;11(7):1438. doi:10.3390/nu11071438.
   PubMed Web of Science ®Google Scholar
• Wang M, Liu J, Zhang Z, Zhang H, Wang N, Chen X, et al. Effects of dietary intervention on inflammatory markers in metabolic syndrome: a systematic review and meta-analysis. Front Nutr. 2022;9:846591. doi:10.3389/fnut.2022.846591.
   PubMed Web of Science ®Google Scholar
• Wilkowska A, Szałach Ł, Cubała WJ. Ketamine in bipolar disorder: a review. Neuropsychiatr Dis Treat. 2020;16:2707–17. doi:10.2147/NDT.S282208.
   PubMed Web of Science ®Google Scholar
• Zeiss R, Gahr M, Graf H. Rediscovering psilocybin as an antidepressive treatment strategy. Pharmaceuticals. 2021;14(10):985. doi:10.3390/ph14100985.
   Web of Science ®Google Scholar
• Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W. Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders. Molecules. 2022;27(8):2520. doi:10.3390/molecules27082520.
   PubMed Web of Science ®Google Scholar
• Wilkowska A, Wiglusz MS, Gałuszko-Wegielnik M, Włodarczyk A, Cubała WJ. Antianhedonic effect of repeated ketamine infusions in patients with treatment resistant depression. Front Psychiatry. 2021;12:704330. doi:10.3389/fpsyt.2021.704330.
   PubMed Web of Science ®Google Scholar
• Gonda X, Dome P, Neill JC, Tarazi FI. Novel antidepressant drugs: beyond monoamine targets. CNS Spectr. 2023;28(1):6–15. doi:10.1017/S1092852921000791.
   PubMed Web of Science ®Google Scholar
• Jha MK, Mathew SJ. Pharmacotherapies for treatment-resistant depression: how antipsychotics fit in the rapidly evolving therapeutic landscape. AJP. 2023;180(3):190–9. doi:10.1176/appi.ajp.20230025.
   Google Scholar
• Lax E. Dna methylation as a therapeutic and diagnostic target in major depressive disorder. Front Behav Neurosci. 2022;16:759052. doi:10.3389/fnbeh.2022.759052.
   PubMed Web of Science ®Google Scholar
• Opie RS, O’Neil A, Jacka FN, Pizzinga J, Itsiopoulos C. A modified Mediterranean dietary intervention for adults with major depression: dietary protocol and feasibility data from the SMILES trial. Nutr Neurosci. 2018;21(7):487–501. doi:10.1080/1028415X.2017.1312841.
   PubMed Web of Science ®Google Scholar
• Azevedo de Lima P, Baldini Prudêncio M, Murakami DK, Pereira de Brito Sampaio L, Figueiredo Neto AM, Teixeira Damasceno NR. Effect of classic ketogenic diet treatment on lipoprotein subfractions in children and adolescents with refractory epilepsy. Nutrition. 2017;33:271–7. doi:10.1016/j.nut.2016.06.016.
   PubMed Web of Science ®Google Scholar
• Fedorovich S, Voronina P, Waseem T. Ketogenic diet versus ketoacidosis: what determines the influence of ketone bodies on neurons? Neural Regen Res. 2018;13(12):2060. doi:10.4103/1673-5374.241442.
   PubMed Web of Science ®Google Scholar